Atropine sulphate ophthalmic - Sinphar Pharmaceutical

Drug Profile

Atropine sulphate ophthalmic - Sinphar Pharmaceutical

Alternative Names: "Apricot" atropine eye drops 0.125%; "Apricot" atropine eye drops 0.3%; Atropine Eye Drops 0.125% "SINPHAR"; Atropine Eye Drops 0.3% "SINPHAR"

Latest Information Update: 19 Jul 2017

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Sinphar Pharmaceutical
  • Class Alkaloids; Small molecules; Tropanes
  • Mechanism of Action Cholinergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Eye disorders; Mydriasis

Most Recent Events

  • 19 Jul 2017 Chemical structure information added
  • 31 May 2004 Launched for Eye disorders (Cycloplegia) in Taiwan (Ophthalmic) after May 2004 (Sinphar Pharmaceutical website, July 2017)
  • 31 May 2004 Launched for Mydriasis in Taiwan (Ophthalmic) after May 2004 (Sinphar Pharmaceutical website, July 2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top